Since severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) began to spread in
late 2019, laboratories around the world have widely used whole genome sequencing …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative virus of the
coronavirus disease 2019 (COVID-19), has been identified in China in late December 2019 …

Objectives Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in
Wuhan, China, in December 2019 and has been rapidly spreading worldwide. Although the …

New SARS-CoV-2 mutants have been continuously indentified with enhanced transmission
ever since its outbreak in early 2020. As an RNA virus, SARS-CoV-2 has a high mutation …

Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic caused by it,
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been undergoing a …

The spread of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variants,
such as B. 1.1. 7 and B. 1.351, has become a crucial issue worldwide. Therefore, we began …

Since the beginning of the SARS-CoV-2 pandemic, there has been international concern
about the emergence of virus variants with mutations that increase transmissibility, enhance …

Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) circulates
in the world and acquires mutations during evolution. To identify the new emergent variants …

Recently, many SARS-CoV-2 variants including 501Y. V1, 501Y. V2 and 501Y. V3 were
detected in different regions (Table S1) and drew great attention from all over the world. The …

The high transmission and mortality rates associated with SARS-CoV-2 have led to tragic
consequences worldwide. Large-scale whole-genome sequencing of the SARS-CoV-2 …